Similar articles

• Clinical applications of the antiprogestins.

  Kettel LM. Kettel LM. Clin Obstet Gynecol. 1995 Dec;38(4):921-34. doi: 10.1097/00003081-199538040-00026. Clin Obstet Gynecol. 1995. PMID: 8616987 Review. No abstract available.
• [Anti progestins].

  Fujimoto J. Fujimoto J. Nihon Rinsho. 2006 Apr;64 Suppl 4:447-51. Nihon Rinsho. 2006. PMID: 16689349 Review. Japanese. No abstract available.
• RU486 (mifepristone): mechanisms of action and clinical uses.

  Cadepond F, Ulmann A, Baulieu EE. Cadepond F, et al. Annu Rev Med. 1997;48:129-56. doi: 10.1146/annurev.med.48.1.129. Annu Rev Med. 1997. PMID: 9046951 Review.
• [The molecular mechanisms of the action of antiprogestins].

  Kareva EN, Solov'eva EV, Kirpichnikova NV, Tumanov AV. Kareva EN, et al. Eksp Klin Farmakol. 1999 Jul-Aug;62(4):72-6. Eksp Klin Farmakol. 1999. PMID: 10513344 Review. Russian. No abstract available.
• [Mifepristone--a new antiprogesterone in obstetrics and gynecology].

  Aschkenazi S, Levy T, Ben-Rafael Z. Aschkenazi S, et al. Harefuah. 2001 May;140(5):429-34. Harefuah. 2001. PMID: 11419069 Review. Hebrew. No abstract available.